NEW YORK, Nov. 5—Molecular Mining and NextGen Sciences are collaborating to develop and produce protein biochips, Molecular Mining announced Wednesday.
In the partnership, NextGen will use Molecular Mining’s GeneLinker gene expression analysis software. The software package, launched last spring, enables data filtering and transformation, sorting and clustering, and classification and prioritization of genes along with a suite of visualization tools.
NextGen, based in Huntingdon, Cambridgeshire, UK, was founded in 2000 to develop technologies for genomic and proteomic research. It is now developing a novel technique of attaching proteins to biochip surfaces, and also working on developing new substances for use in the biochip surfaces themselves
“When you are working with protein biochips, there is a lot of information associated with the proteins and the analysis,” said company business development director Linda Cammish. “That sort of data processing really isn’t our core technology, and nor do we wish it to be. Therefore our process has been to form a number of partnerships, including the one with MMC, since their strength is in the use of high performance analysis software.”
The collaboration will help Molecular Mining evaluate future need for protein biochip data, said the company in a statement.There are no explicit financial agreements to the research partnership, a company official said.